[Efficacy of the immunostimulant Broncho-Vaxom].
In a 6-month placebo-controlled double-blind multicenter study in 230 patients with recurrent respiratory tract infections, the therapeutic efficacy of Broncho-Vaxom was demonstrated by comparing infection incidence and severity as well as antibacterial medication. Investigators and patients agreed that Broncho-Vaxom exerts a significantly greater protective effect than placebo. Reports of side effects were more frequent with placebo as compared to Broncho-Vaxom.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D001419:Bacteria; D002457:Cell Extracts; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D000095983:Bacterial Lysates
D000276:Adjuvants, Immunologic; D002457:Cell Extracts; C030259:Broncho-Vaxom; D000095983:Bacterial Lysates
Die Wirksamkeit des Immunostimulators Broncho-Vaxom.